TickerFacts.

Edwards Lifesciences Corp (EW): Cash & Equivalents

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2023-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$2.94B
As of 2025-12-31
$2.91B
As of 2026-06-30
$3.05B2008-12-31: $218.70M2009-12-31: $334.10M2010-12-31: $396.10M2011-03-31: $325.20M2011-06-30: $175.60M2011-09-30: $244.00M2011-12-31: $171.20M2012-12-31: $310.90M2013-12-31: $420.40M2014-12-31: $653.80M2015-12-31: $718.40M2016-12-31: $930.10M2017-12-31: $818.30M2018-12-31: $714.10M2019-12-31: $1.18B2020-12-31: $1.18B2021-12-31: $862.80M2022-12-31: $769.00M2023-12-31: $1.13B2024-12-31: $3.05B2025-12-31: $2.94B$2.94B
2008-12-31 Cash & Equivalents (USD) 2025-12-31
Period endedCash & EquivalentsChange YoYSource filing
2025-12-31$2.94B-3.5%2026-02-25, Balance as of period end
2024-12-31$3.05B+168.9%2026-02-25, Balance as of period end
2023-12-31$1.13Bn/c2025-02-28, Balance as of period end
2022-12-31$769.00M-10.9%2024-02-12, Balance as of period end
2021-12-31$862.80M-27.1%2024-02-12, Balance as of period end
2020-12-31$1.18B+0.3%2023-02-13, Balance as of period end
2019-12-31$1.18B+65.1%2022-02-14, Balance as of period end
2018-12-31$714.10M-12.7%2021-02-12, Balance as of period end
2017-12-31$818.30M-12.0%2019-02-15, Balance as of period end
2016-12-31$930.10M+29.5%2019-02-15, Balance as of period end
2015-12-31$718.40M+9.9%2018-02-16, Balance as of period end
2014-12-31$653.80M+55.5%2017-02-17, Balance as of period end
2013-12-31$420.40M+35.2%2016-02-19, Balance as of period end
2012-12-31$310.90M+81.6%2015-02-20, Balance as of period end
2011-12-31$171.20Mn/a2014-02-28, Balance as of period end
2011-09-30$244.00Mn/a2012-02-27, Balance as of period end
2011-06-30$175.60Mn/a2012-02-27, Balance as of period end
2011-03-31$325.20Mn/a2012-02-27, Balance as of period end
2010-12-31$396.10M+18.6%2013-02-28, Balance as of period end
2009-12-31$334.10M+52.8%2012-02-27, Balance as of period end
2008-12-31$218.70Mn/a2011-02-28, Balance as of period end

Cash & Equivalents at similar companies

Companies with the same SEC industry code (Orthopedic, Prosthetic & Surgical Appliances & Supplies), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCash & EquivalentsChange YoY
Edwards Lifesciences Corp (EW)2025-12-31$2.94B-3.5%
Zimmer Biomet Holdings, Inc. (ZBH)2025-12-31$591.90M+12.6%
Align Technology Inc (ALGN)2025-12-31$1.09B+4.9%
Intuitive Surgical Inc (ISRG)2025-12-31$3.37B+66.1%
Enovis Corp (ENOV)2025-12-31$36.39M-24.5%
MSA Safety Inc (MSA)2025-12-31$165.07M+0.3%
Cadre Holdings, Inc. (CDRE)2025-12-31$122.90M-1.6%
Inogen Inc (INGN)2025-12-31$103.73M-8.8%
Establishment Labs Holdings Inc. (ESTA)2025-12-31$75.57M-16.4%

Compare EW, ZBH, ALGN, ISRG side by side · Screen every company in Orthopedic, Prosthetic & Surgical Appliances & Supplies ↗